Absci (ABSI) Financials

$5.13 -0.41 (-7.40%)

Closing price 05/15/2026 04:00 PM Eastern

Extended Trading

$5.10 -0.04 (-0.68%)

As of 05/15/2026 07:55 PM Eastern

Annual Income Statements for Absci

This table shows Absci's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024	2025
Period end date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	-49	-103	-105	-111	-103	-115
Consolidated Net Income / (Loss)	-14	-101	-105	-111	-103	-115
Net Income / (Loss) Continuing Operations	-32	-101	-105	-111	-103	-115
Total Pre-Tax Income	-14	-110	-105	-110	-103	-115
Total Operating Income	-13	-75	-107	-116	-109	-120
Total Gross Profit	4.78	4.78	5.75	5.72	4.53	2.80
Total Revenue	4.78	4.78	5.75	5.72	4.53	2.80
Operating Revenue	4.78	4.78	5.75	5.72	4.53	2.80
Total Cost of Revenue	0.00	0.00	0.00	0.00	0.00	0.00
Total Operating Expenses	36	80	112	121	113	123
Selling, General & Admin Expense	5.50	29	41	38	36	35
Research & Development Expense	11	45	59	48	64	81
Depreciation Expense	1.13	6.65	13	14	13	12
Other Operating Expenses / (Income)	18	-	-	-	0.00	-5.10
Total Other Income / (Expense), net	-1.05	-35	1.39	5.05	5.85	5.20
Interest Expense	0.63	3.43	0.97	1.01	0.57	0.21
Other Income / (Expense), net	-0.42	-31	2.36	6.06	6.42	5.41
Income Tax Expense	0.00	-8.90	-0.46	0.10	0.07	0.07
Basic Earnings per Share	($3.19)	($2.08)	($1.15)	($1.20)	($0.94)	($0.84)
Weighted Average Basic Shares Outstanding	15.49M	49.69M	90.85M	92.03M	110.24M	136.78M
Diluted Earnings per Share	($3.19)	($2.08)	($1.15)	($1.20)	($0.94)	($0.84)
Weighted Average Diluted Shares Outstanding	15.49M	49.69M	90.85M	92.03M	110.24M	136.78M
Weighted Average Basic & Diluted Shares Outstanding	-	92.77M	92.32M	112.78M	127.33M	153.02M

This table shows Absci's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Income / (Loss) Attributable to Common Shareholders	-22	-24	-22	-25	-27	-29	-26	-31	-29	-30	-30
Consolidated Net Income / (Loss)	-22	-24	-22	-25	-27	-29	-26	-31	-29	-30	-30
Net Income / (Loss) Continuing Operations	-22	-24	-22	-25	-27	-29	-26	-31	-29	-30	-30
Total Pre-Tax Income	-22	-23	-22	-25	-27	-29	-26	-30	-29	-30	-30
Total Operating Income	-23	-25	-23	-27	-29	-30	-28	-31	-30	-31	-31
Total Gross Profit	0.74	0.34	0.90	1.27	1.70	0.67	1.18	0.59	0.38	0.65	0.00
Total Revenue	0.74	0.34	0.90	1.27	1.70	0.67	1.18	0.59	0.38	0.65	0.00
Operating Revenue	0.74	0.34	0.90	1.27	1.70	0.67	1.18	0.59	0.38	0.65	0.00
Total Cost of Revenue	0.00	-	0.00	0.00	0.00	-	0.00	0.00	0.00	-	0.00
Total Operating Expenses	24	25	24	28	31	30	29	32	31	32	31
Selling, General & Admin Expense	9.51	9.32	8.74	9.35	9.26	8.83	9.47	8.53	8.44	8.62	9.06
Research & Development Expense	11	12	12	15	18	18	16	20	19	25	19
Depreciation Expense	3.51	3.48	3.42	3.38	3.36	3.23	3.07	3.00	2.84	2.83	2.73
Total Other Income / (Expense), net	1.34	1.24	1.54	1.97	1.53	0.81	1.38	0.96	1.55	1.32	1.27
Interest Expense	0.23	0.20	0.18	0.15	0.13	0.11	0.08	0.06	0.05	0.03	0.02
Other Income / (Expense), net	1.57	1.45	1.71	2.12	1.66	0.92	1.46	1.01	1.60	1.35	1.28
Income Tax Expense	0.03	0.05	0.01	0.00	0.04	0.02	-0.00	0.13	0.10	-0.16	0.02
Basic Earnings per Share	($0.24)	($0.25)	($0.22)	($0.22)	($0.24)	($0.26)	($0.21)	($0.24)	($0.20)	($0.19)	($0.19)
Weighted Average Basic Shares Outstanding	92.22M	92.03M	99.39M	112.93M	113.61M	110.24M	124.46M	127.59M	143.77M	136.78M	152.96M
Diluted Earnings per Share	($0.24)	($0.25)	($0.22)	($0.22)	($0.24)	($0.26)	($0.21)	($0.24)	($0.20)	($0.19)	($0.19)
Weighted Average Diluted Shares Outstanding	92.22M	92.03M	99.39M	112.93M	113.61M	110.24M	124.46M	127.59M	143.77M	136.78M	152.96M
Weighted Average Basic & Diluted Shares Outstanding	92.94M	112.78M	113.08M	113.56M	114.86M	127.33M	127.56M	149.52M	150.37M	153.02M	155.91M

This table details how cash moves in and out of Absci's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024	2025
Period end date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	58	208	-203	13	-31	-37
Net Cash From Operating Activities	-11	-61	-81	-65	-72	-93
Net Cash From Continuing Operating Activities	-11	-61	-81	-65	-72	-93
Net Income / (Loss) Continuing Operations	-14	-101	-105	-111	-103	-115
Consolidated Net Income / (Loss)	-14	-101	-105	-111	-103	-115
Depreciation Expense	1.13	6.65	13	14	13	12
Amortization Expense	-	0.00	-0.69	-2.67	-3.74	-2.54
Non-Cash Adjustments To Reconcile Net Income	1.24	45	13	33	19	13
Changes in Operating Assets and Liabilities, net	1.01	-12	-1.32	1.85	1.61	-0.16
Net Cash From Investing Activities	-2.17	-67	-127	82	-42	-50
Net Cash From Continuing Investing Activities	-2.17	-67	-127	82	-42	-50
Purchase of Property, Plant & Equipment	-2.18	-38	-16	-0.86	-0.40	-1.11
Purchase of Investments	0.00	-1.20	-109	-147	-186	-120
Sale of Property, Plant & Equipment	0.01	0.00	0.13	0.25	0.94	1.31
Sale and/or Maturity of Investments	-	0.00	5.00	230	144	70
Net Cash From Financing Activities	71	336	5.24	-4.48	83	106
Net Cash From Continuing Financing Activities	71	336	5.24	-4.48	83	106
Repayment of Debt	-0.50	-1.60	-4.65	-3.01	-3.39	-3.12
Issuance of Common Equity	0.00	210	0.66	0.86	87	109
Other Financing Activities, net	-1.09	-2.55	-2.80	-2.33	-0.64	-0.08
Cash Interest Paid	0.51	0.65	0.90	0.97	0.56	0.18

This table details how cash moves in and out of Absci's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Change in Cash & Equivalents	8.85	2.80	-13	-16	-5.44	3.07	5.91	-8.84	-28	-5.79	-11
Net Cash From Operating Activities	-10	-15	-18	-17	-21	-17	-22	-17	-25	-29	-26
Net Cash From Continuing Operating Activities	-10	-15	-18	-17	-21	-17	-22	-17	-25	-29	-26
Net Income / (Loss) Continuing Operations	-22	-24	-22	-25	-27	-29	-26	-31	-29	-30	-30
Consolidated Net Income / (Loss)	-22	-24	-22	-25	-27	-29	-26	-31	-29	-30	-30
Depreciation Expense	3.51	3.48	3.42	3.38	3.36	3.23	3.07	3.00	2.84	2.83	2.73
Amortization Expense	-0.63	-0.40	-0.63	-1.21	-1.12	-0.78	-0.70	-0.67	-0.65	-0.53	-0.42
Non-Cash Adjustments To Reconcile Net Income	2.56	3.18	3.59	5.28	5.52	5.07	4.91	4.75	4.40	-0.84	4.38
Changes in Operating Assets and Liabilities, net	6.19	2.36	-2.26	0.46	-1.09	4.50	-2.78	6.61	-2.92	-1.08	-3.40
Net Cash From Investing Activities	20	19	-77	1.26	15	19	-15	9.04	-64	20	7.36
Net Cash From Continuing Investing Activities	20	19	-77	1.26	15	19	-15	9.04	-64	20	7.36
Purchase of Property, Plant & Equipment	-0.31	-0.02	0.00	-0.33	-0.05	-0.02	-0.03	-0.22	-0.96	0.10	-0.03
Purchase of Investments	-30	-25	-97	-34	-28	-27	-40	-18	-77	15	-19
Sale of Property, Plant & Equipment	0.01	0.13	0.15	-	0.10	0.70	0.11	1.07	-	0.13	0.00
Sale and/or Maturity of Investments	50	44	21	36	43	45	25	26	14	4.31	26
Net Cash From Financing Activities	-0.92	-1.24	81	-0.13	0.49	0.99	43	-1.00	60	3.84	7.56
Net Cash From Continuing Financing Activities	-0.92	-1.24	81	-0.13	0.49	0.99	43	-1.00	60	3.84	7.56
Repayment of Debt	-0.76	-0.84	-0.87	-0.80	-0.82	-0.90	-0.76	-1.08	-0.78	-0.50	-0.46
Issuance of Common Equity	0.38	0.14	82	0.76	1.39	1.95	44	0.10	61	4.34	8.02
Other Financing Activities, net	-0.54	-0.53	-0.40	-0.09	-0.08	-0.07	-0.05	-0.03	-0.01	-0.00	0.00

This table presents Absci's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024	2025
Period end date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	89	426	321	217	214	216
Total Current Assets	73	273	187	121	134	150
Cash & Equivalents	70	253	60	72	41	20
Short-Term Investments	-	-	104	25	71	124
Prepaid Expenses	1.77	8.57	5.86	4.54	5.46	5.28
Plant, Property, & Equipment, net	0.00	52	0.00	0.00	29	21
Total Noncurrent Assets	15	101	134	97	51	46
Intangible Assets	0.00	55	52	48	45	42
Other Noncurrent Operating Assets	15	25	61	48	5.73	4.35
Total Liabilities & Shareholders' Equity	89	426	321	217	214	216
Total Liabilities	22	60	47	41	34	27
Total Current Liabilities	10	34	30	30	29	23
Short-Term Debt	1.54	2.40	2.95	16	15	0.87
Accounts Payable	2.12	8.39	2.41	1.50	10	19
Current Deferred Revenue	2.63	1.35	0.45	3.17	1.12	0.74
Other Current Liabilities	2.25	4.29	3.99	2.32	1.61	1.81
Total Noncurrent Liabilities	11	26	16	12	5.82	4.08
Noncurrent Deferred Revenue	-	-	0.00	0.97	0.00	0.44
Other Noncurrent Operating Liabilities	4.56	24	7.35	0.30	4.56	3.65
Total Equity & Noncontrolling Interests	-89	366	274	176	179	189
Total Preferred & Common Equity	-89	366	274	176	179	189
Preferred Stock	-	0.00	0.00	0.00	0.00	0.00
Total Common Equity	-89	366	274	176	179	189
Common Stock	0.64	557	570	583	689	814
Retained Earnings	-90	-191	-296	-406	-510	-625
Accumulated Other Comprehensive Income / (Loss)	0.00	-0.01	-0.12	-0.04	-0.00	0.59

This table presents Absci's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026
Total Assets	339	296	254	236	275	256	235	232	210	245	196
Total Current Assets	201	165	148	135	182	165	150	156	137	175	132
Cash & Equivalents	107	11	61	70	59	43	38	47	38	9.48	8.63
Short-Term Investments	74	133	64	44	103	102	89	87	79	143	117
Prepaid Expenses	4.84	4.71	5.23	4.40	3.86	3.39	5.78	4.54	3.04	5.18	6.27
Plant, Property, & Equipment, net	0.00	50	0.00	0.00	39	0.00	0.00	27	0.00	23	19
Total Noncurrent Assets	138	80	106	102	54	90	85	49	72	47	45
Intangible Assets	52	51	50	49	47	47	46	44	43	42	41
Other Noncurrent Operating Assets	64	8.21	56	53	6.93	44	39	5.40	29	4.63	4.08
Total Liabilities & Shareholders' Equity	339	296	254	236	275	256	235	232	210	245	196
Total Liabilities	46	42	39	40	35	34	34	34	37	35	24
Total Current Liabilities	30	27	25	28	25	25	27	27	31	30	20
Short-Term Debt	2.35	3.08	3.15	3.21	3.30	3.12	3.27	15	15	14	0.41
Accounts Payable	1.86	1.93	1.85	1.91	1.65	1.69	1.67	4.95	8.21	4.59	17
Current Deferred Revenue	0.68	0.36	0.50	0.35	3.06	1.97	1.78	1.10	0.95	1.08	0.45
Other Current Liabilities	4.16	3.74	3.28	2.83	1.87	1.82	1.71	1.69	1.71	1.76	1.86
Total Noncurrent Liabilities	16	15	13	12	9.50	8.57	7.21	6.37	5.20	4.94	3.59
Capital Lease Obligations	9.11	7.23	0.25	6.16	5.33	5.26	4.85	4.00	3.55	-	2.15
Noncurrent Deferred Revenue	-	-	-	-	0.18	0.00	0.00	-	-	-	0.64
Other Noncurrent Operating Liabilities	0.03	0.00	6.42	0.00	0.08	0.02	0.03	1.69	1.48	4.88	0.81
Total Equity & Noncontrolling Interests	293	254	215	196	240	221	201	199	173	210	172
Total Preferred & Common Equity	293	254	215	196	240	221	201	199	173	210	172
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	293	254	215	196	240	221	201	199	173	210	172
Common Stock	569	573	577	579	669	675	682	735	740	805	826
Retained Earnings	-276	-319	-361	-383	-428	-453	-481	-536	-567	-595	-654
Accumulated Other Comprehensive Income / (Loss)	0.03	-0.10	-0.15	-0.06	-0.13	-0.11	0.25	0.02	0.31	0.50	0.30

This table displays calculated financial ratios and metrics derived from Absci's official financial filings.

Metric	2020	2021	2022	2023	2024	2025
Period end date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
DEI Shares Outstanding	0.00	92,591,472.00	-	-	-	150,371,531.00
DEI Adjusted Shares Outstanding	0.00	92,591,472.00	-	-	-	150,371,531.00
DEI Earnings Per Adjusted Shares Outstanding	0.00	-1.12	-	-	-	-0.77
Growth Metrics	-	-	-	-	-	-
Profitability Metrics	-	-	-	-	-	-
Net Operating Profit after Tax (NOPAT)	-9.31	-53	-75	-81	-76	-84
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-39.93%	-38.05%	-44.25%
Earnings before Interest and Taxes (EBIT)	-14	-106	-104	-109	-102	-115
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-13	-100	-92	-98	-93	-106
Valuation Ratios	-	-	-	-	-	-
Leverage & Solvency	-	-	-	-	-	-
Liquidity Ratios	-	-	-	-	-	-
Cash Flow Metrics	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-154	-75	-63	-60	-63
Efficiency Ratios	-	-	-	-	-	-
Capital & Investment Metrics	-	-	-	-	-	-
Invested Capital	5.58	107	107	89	72	46
Increase / (Decrease) in Invested Capital	0.00	101	0.09	-18	-17	-21
Book Value per Share	($5.77)	$3.95	$2.97	$1.90	$1.56	$1.26
Tangible Book Value per Share	($5.77)	$3.13	$2.18	$1.38	$1.17	$0.98
Total Capital	75	370	286	202	200	190
Total Debt	8.44	3.52	12	26	21	0.87
Total Long-Term Debt	6.91	1.12	8.73	10	5.69	0.00
Net Debt	-61	-260	-168	-88	-107	-143
Capital Expenditures (CapEx)	2.17	38	16	0.61	-0.54	-0.21
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-5.19	-21	-20	-6.82	-7.71	-17
Debt-free Net Working Capital (DFNWC)	65	242	160	107	121	128
Net Working Capital (NWC)	63	239	157	91	105	127
Net Nonoperating Expense (NNE)	5.04	48	30	30	27	31
Net Nonoperating Obligations (NNO)	-61	-260	-168	-88	-107	-143
Total Depreciation and Amortization (D&A)	1.13	6.65	12	11	9.65	9.20
Earnings Adjustments	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	($2.08)	($1.15)	($1.20)	($0.94)	($0.84)
Adjusted Weighted Average Basic Shares Outstanding	0.00	49.69M	90.85M	92.03M	110.24M	136.78M
Adjusted Diluted Earnings per Share	$0.00	($2.08)	($1.15)	($1.20)	($0.94)	($0.84)
Adjusted Weighted Average Diluted Shares Outstanding	0.00	49.69M	90.85M	92.03M	110.24M	136.78M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	92.77M	92.32M	112.78M	127.33M	153.02M
Normalized Net Operating Profit after Tax (NOPAT)	-9.31	-53	-75	-66	-76	-84
Debt Service Ratios	-	-	-	-	-	-
Payout Ratios	-	-	-	-	-	-

This table displays calculated financial ratios and metrics derived from Absci's official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
DEI Shares Outstanding	-	-	-	-	-	-	127,333,887.00	127,559,352.00	149,522,647.00	150,371,531.00	153,021,263.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	127,333,887.00	127,559,352.00	149,522,647.00	150,371,531.00	153,021,263.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-0.21	-0.24	-0.19	-0.20	-0.20
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-68.59%	-78.29%	-29.24%	-62.28%	128.63%	96.75%	31.29%	-53.31%	-77.78%	-	-100.00%
EBITDA Growth	21.10%	-20.37%	6.65%	42.08%	-32.62%	-30.67%	-25.77%	-25.07%	-5.48%	-	-14.05%
EBIT Growth	20.38%	-18.33%	5.39%	40.59%	-25.31%	-23.87%	-20.58%	-23.50%	-4.87%	-	-12.53%
NOPAT Growth	16.68%	-17.29%	4.03%	37.84%	-24.00%	-20.35%	-18.01%	-17.48%	-4.36%	-	-11.24%
Net Income Growth	19.31%	-20.92%	5.91%	40.61%	-24.57%	-23.10%	-19.89%	-23.51%	-4.77%	-	-12.35%
EPS Growth	20.00%	-25.00%	15.38%	51.11%	0.00%	-4.00%	4.55%	-9.09%	16.67%	-	9.52%
Operating Cash Flow Growth	45.59%	19.64%	11.21%	12.43%	-100.10%	-13.68%	-22.26%	-0.18%	-20.74%	-	-20.46%
Free Cash Flow Firm Growth	159.18%	104.63%	188.33%	52.72%	-143.44%	-701.54%	-164.05%	-100.58%	-12.01%	-	87.44%
Invested Capital Growth	-28.60%	-16.88%	-33.51%	-16.69%	-15.98%	-18.85%	-7.87%	-18.37%	-19.06%	-	-28.95%
Revenue Q/Q Growth	-77.90%	-54.57%	165.68%	41.43%	33.94%	-60.91%	77.29%	-49.70%	-36.26%	-	-100.00%
EBITDA Q/Q Growth	51.33%	-7.21%	5.95%	-18.03%	-11.44%	-5.63%	9.48%	-17.38%	6.02%	-	0.50%
EBIT Q/Q Growth	47.52%	-7.19%	6.47%	-12.91%	-10.70%	-5.96%	8.95%	-15.65%	6.01%	-	0.44%
NOPAT Q/Q Growth	45.79%	-6.16%	5.02%	-13.72%	-8.14%	-3.04%	6.87%	-13.21%	3.95%	-	0.63%
Net Income Q/Q Growth	47.22%	-7.05%	6.67%	-12.63%	-10.70%	-5.79%	9.10%	-16.03%	6.09%	-	-0.13%
EPS Q/Q Growth	46.67%	-4.17%	12.00%	0.00%	-9.09%	-8.33%	19.23%	-14.29%	16.67%	-	0.00%
Operating Cash Flow Q/Q Growth	46.13%	-44.02%	-19.71%	5.71%	-23.09%	18.17%	-28.74%	22.74%	-48.35%	-	9.85%
Free Cash Flow Firm Q/Q Growth	275.59%	-95.82%	11.25%	-120.96%	-61.33%	42.14%	-227.34%	34.36%	9.91%	-	-559.76%
Invested Capital Q/Q Growth	-4.32%	8.33%	6.07%	-4.48%	-3.51%	4.63%	-4.47%	-15.37%	-4.32%	-	6.07%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	-	0.00%
EBITDA Margin	-2,533.20%	-5,977.81%	-2,116.04%	-1,765.98%	-1,469.37%	-3,970.08%	-2,026.97%	-4,730.35%	-6,974.34%	-	0.00%
Operating Margin	-3,132.12%	-7,319.23%	-2,616.70%	-2,104.02%	-1,698.71%	-4,477.29%	-2,351.91%	-5,293.93%	-7,977.25%	-	0.00%
EBIT Margin	-2,920.83%	-6,891.42%	-2,426.17%	-1,937.01%	-1,600.88%	-4,338.80%	-2,228.24%	-5,123.44%	-7,554.76%	-	0.00%
Profit (Net Income) Margin	-2,956.18%	-6,965.98%	-2,447.10%	-1,948.82%	-1,610.70%	-4,358.35%	-2,234.61%	-5,154.97%	-7,594.18%	-	0.00%
Tax Burden Percent	100.15%	100.20%	100.05%	100.00%	100.14%	100.07%	99.98%	100.43%	100.36%	-	100.06%
Interest Burden Percent	101.05%	100.88%	100.81%	100.61%	100.48%	100.38%	100.30%	100.18%	100.16%	-	100.06%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%
Return on Invested Capital (ROIC)	-154.87%	-300.05%	-104.88%	-61.07%	-66.45%	-177.00%	-110.64%	-237.01%	-252.74%	-	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	-150.99%	-295.17%	-101.29%	-56.75%	-60.65%	-168.64%	-105.94%	-230.54%	-247.45%	-	0.00%
Return on Net Nonoperating Assets (RNNOA)	90.39%	167.25%	63.00%	36.39%	37.69%	92.43%	71.35%	154.99%	172.69%	-	0.00%
Return on Equity (ROE)	-64.48%	-132.80%	-41.88%	-24.68%	-28.76%	-84.57%	-39.28%	-82.02%	-80.06%	-	0.00%
Cash Return on Invested Capital (CROIC)	-46.37%	-64.38%	-45.60%	-69.55%	-79.20%	-74.13%	-102.32%	-107.22%	-112.93%	-	-113.17%
Operating Return on Assets (OROA)	-70.39%	-146.40%	-45.46%	-24.70%	-28.56%	-91.31%	-42.29%	-91.10%	-88.57%	-	0.00%
Return on Assets (ROA)	-71.24%	-147.99%	-45.85%	-24.85%	-28.74%	-91.72%	-42.42%	-91.66%	-89.03%	-	0.00%
Return on Common Equity (ROCE)	-64.48%	-132.80%	-41.88%	-24.68%	-28.76%	-84.57%	-39.28%	-82.02%	-80.06%	-	0.00%
Return on Equity Simple (ROE_SIMPLE)	-54.22%	0.00%	-45.47%	-41.66%	-48.51%	0.00%	-54.06%	0.00%	0.00%	-	0.00%
Net Operating Profit after Tax (NOPAT)	-16	-17	-16	-19	-20	-21	-19	-22	-21	-22	-22
NOPAT Margin	-2,192.49%	-5,123.46%	-1,831.69%	-1,472.81%	-1,189.09%	-3,134.11%	-1,646.34%	-3,705.75%	-5,584.07%	-	0.00%
Net Nonoperating Expense Percent (NNEP)	-3.88%	-4.88%	-3.60%	-4.32%	-5.80%	-8.36%	-4.69%	-6.47%	-5.29%	-	-6.32%
Return On Investment Capital (ROIC_SIMPLE)	-	-8.55%	-	-	-	-10.41%	-8.87%	-11.46%	-9.40%	-11.42%	-12.37%
Cost of Revenue to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%
SG&A Expenses to Revenue	1,277.55%	2,758.58%	973.72%	735.91%	544.15%	1,327.52%	803.39%	1,438.11%	2,233.07%	-	0.00%
R&D to Revenue	1,482.39%	3,629.88%	1,362.58%	1,201.65%	1,057.32%	2,763.46%	1,387.96%	3,449.92%	5,092.33%	-	0.00%
Operating Expenses to Revenue	3,232.12%	7,419.23%	2,716.70%	2,204.02%	1,798.71%	4,577.29%	2,451.91%	5,393.93%	8,077.25%	-	0.00%
Earnings before Interest and Taxes (EBIT)	-22	-23	-22	-25	-27	-29	-26	-30	-29	-30	-30
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-19	-20	-19	-22	-25	-26	-24	-28	-26	-27	-27
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.62	2.22	2.67	1.57	2.15	1.68	1.61	1.89	2.16	-	2.67
Price to Tangible Book Value (P/TBV)	0.83	3.05	3.32	1.99	2.79	2.24	2.07	2.52	2.71	-	3.50
Price to Revenue (P/Rev)	17.64	68.27	119.81	107.17	103.11	66.37	66.38	79.22	161.47	-	283.20
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.10	3.42	6.37	2.78	4.38	2.69	2.76	3.66	5.39	-	6.88
Enterprise Value to Revenue (EV/Rev)	1.12	52.96	88.85	60.94	71.59	42.73	39.36	51.38	106.52	-	207.23
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.08	0.15	0.05	0.05	0.05	0.12	0.10	0.11	0.07	-	0.01
Long-Term Debt to Equity	0.06	0.06	0.04	0.04	0.03	0.03	0.02	0.02	0.00	-	0.01
Financial Leverage	-0.60	-0.57	-0.62	-0.64	-0.62	-0.55	-0.67	-0.67	-0.70	-	-0.68
Leverage Ratio	1.18	1.19	1.16	1.17	1.19	1.21	1.16	1.18	1.17	-	1.15
Compound Leverage Factor	1.19	1.21	1.16	1.17	1.19	1.22	1.16	1.18	1.17	-	1.16
Debt to Total Capital	7.06%	12.99%	4.90%	4.94%	4.86%	10.57%	9.13%	9.62%	6.29%	-	1.47%
Short-Term Debt to Total Capital	1.52%	7.91%	1.31%	1.34%	1.55%	7.73%	6.99%	7.68%	6.26%	-	0.24%
Long-Term Debt to Total Capital	5.54%	5.09%	3.59%	3.60%	3.31%	2.84%	2.14%	1.94%	0.03%	-	1.23%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%
Common Equity to Total Capital	92.94%	87.01%	95.10%	95.06%	95.14%	89.43%	90.87%	90.38%	93.71%	-	98.53%
Debt to EBITDA	-0.16	-0.27	-0.13	-0.14	-0.12	-0.23	-0.20	-0.18	-0.13	-	-0.02
Net Debt to EBITDA	1.21	0.89	1.71	1.87	1.53	1.15	1.33	1.11	1.48	-	1.13
Long-Term Debt to EBITDA	-0.12	-0.11	-0.09	-0.10	-0.08	-0.06	-0.05	-0.04	0.00	-	-0.02
Debt to NOPAT	-0.19	-0.33	-0.15	-0.17	-0.14	-0.28	-0.25	-0.22	-0.17	-	-0.03
Net Debt to NOPAT	1.46	1.08	2.06	2.18	1.82	1.41	1.64	1.40	1.86	-	1.43
Long-Term Debt to NOPAT	-0.15	-0.13	-0.11	-0.12	-0.10	-0.07	-0.06	-0.05	0.00	-	-0.02
Altman Z-Score	-0.16	3.25	9.31	4.01	5.08	2.06	2.78	1.76	4.81	-	7.17
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	4.82	4.08	7.19	6.49	5.63	4.67	5.72	4.39	5.89	-	6.59
Quick Ratio	4.09	3.38	6.39	5.71	4.82	3.92	4.96	3.77	5.17	-	6.28
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	16	0.69	21	-4.43	-7.15	-4.14	-14	-8.89	-8.01	-0.26	-1.70
Operating Cash Flow to CapEx	-3,500.34%	0.00%	0.00%	-5,057.96%	0.00%	0.00%	0.00%	0.00%	-2,601.98%	-	-101,180.77%
Free Cash Flow to Firm to Interest Expense	71.87	3.37	120.13	-29.54	-55.00	-37.95	-171.41	-158.73	-177.95	-	-94.46
Operating Cash Flow to Interest Expense	-45.24	-73.15	-101.49	-112.29	-159.48	-155.63	-276.44	-301.30	-556.24	-	-1,461.50
Operating Cash Flow Less CapEx to Interest Expense	-46.54	-72.61	-100.65	-114.51	-159.12	-149.47	-275.33	-286.18	-577.62	-	-1,462.94
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.02	0.02	0.02	0.01	0.02	0.02	0.02	0.02	0.01	-	0.01
Accounts Receivable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
Fixed Asset Turnover	0.00	0.00	0.12	0.00	0.00	0.00	0.15	0.00	0.00	-	0.07
Accounts Payable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
Days Payable Outstanding (DPO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
Cash Conversion Cycle (CCC)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	82	89	75	71	69	72	69	58	56	46	49
Invested Capital Turnover	0.07	0.06	0.06	0.04	0.06	0.06	0.07	0.06	0.05	-	0.03
Increase / (Decrease) in Invested Capital	-33	-18	-38	-14	-13	-17	-5.87	-13	-13	-21	-20
Enterprise Value (EV)	7.78	303	475	198	301	194	190	213	300	-	336
Market Capitalization	122	390	641	348	434	301	320	328	455	-	459
Book Value per Share	$2.12	$1.90	$2.13	$1.96	$1.77	$1.56	$1.56	$1.36	$1.41	$1.26	$1.12
Tangible Book Value per Share	$1.59	$1.38	$1.71	$1.55	$1.37	$1.17	$1.22	$1.02	$1.12	$0.98	$0.86
Total Capital	211	202	252	233	212	200	219	192	224	190	175
Total Debt	15	26	12	12	10	21	20	18	14	0.87	2.56
Total Long-Term Debt	12	10	9.07	8.38	7.00	5.69	4.69	3.71	0.07	0.00	2.15
Net Debt	-115	-88	-166	-150	-133	-107	-130	-115	-155	-143	-123
Capital Expenditures (CapEx)	0.30	-0.11	-0.15	0.33	-0.05	-0.67	-0.09	-0.85	0.96	-0.23	0.03
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-20	-6.82	-18	-19	-16	-7.71	-6.07	-13	-9.48	-17	-13
Debt-free Net Working Capital (DFNWC)	110	107	160	143	127	121	144	121	159	128	112
Net Working Capital (NWC)	107	91	157	140	123	105	129	106	145	127	112
Net Nonoperating Expense (NNE)	5.68	6.23	5.53	6.05	7.17	8.14	6.94	8.59	7.60	7.83	8.01
Net Nonoperating Obligations (NNO)	-115	-88	-166	-150	-133	-107	-130	-115	-155	-143	-123
Total Depreciation and Amortization (D&A)	2.88	3.09	2.79	2.17	2.24	2.45	2.37	2.33	2.19	2.30	2.31
Debt-free, Cash-free Net Working Capital to Revenue	-281.98%	-119.34%	-338.17%	-581.88%	-383.58%	-170.14%	-126.02%	-310.54%	-336.59%	-	-823.57%
Debt-free Net Working Capital to Revenue	1,585.02%	1,871.77%	2,988.80%	4,395.17%	3,012.36%	2,661.18%	2,990.47%	2,919.70%	5,660.46%	-	6,931.22%
Net Working Capital to Revenue	1,538.71%	1,591.82%	2,927.06%	4,299.05%	2,934.54%	2,319.70%	2,672.83%	2,563.58%	5,161.14%	-	6,905.74%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.24)	($0.25)	($0.22)	($0.22)	($0.24)	($0.26)	($0.21)	($0.24)	($0.20)	($0.19)	($0.19)
Adjusted Weighted Average Basic Shares Outstanding	92.22M	92.03M	99.39M	112.93M	113.61M	110.24M	124.46M	127.59M	143.77M	136.78M	152.96M
Adjusted Diluted Earnings per Share	($0.24)	($0.25)	($0.22)	($0.22)	($0.24)	($0.26)	($0.21)	($0.24)	($0.20)	($0.19)	($0.19)
Adjusted Weighted Average Diluted Shares Outstanding	92.22M	92.03M	99.39M	112.93M	113.61M	110.24M	124.46M	127.59M	143.77M	136.78M	152.96M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	92.94M	112.78M	113.08M	113.56M	114.86M	127.33M	127.56M	149.52M	150.37M	153.02M	155.91M
Normalized Net Operating Profit after Tax (NOPAT)	-16	-17	-16	-19	-20	-21	-19	-22	-21	-22	-22
Normalized NOPAT Margin	-2,192.49%	-5,123.46%	-1,831.69%	-1,472.81%	-1,189.09%	-3,134.11%	-1,646.34%	-3,705.75%	-5,584.07%	-	0.00%
Pre Tax Income Margin	-2,951.61%	-6,951.78%	-2,445.77%	-1,948.82%	-1,608.52%	-4,355.19%	-2,234.94%	-5,132.88%	-7,566.67%	-	0.00%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-94.90	-114.18	-123.79	-164.00	-209.47	-264.71	-332.54	-542.54	-634.60	-	-1,642.39
NOPAT to Interest Expense	-71.23	-84.89	-93.46	-124.70	-155.59	-191.21	-245.70	-392.41	-469.06	-	-1,199.57
EBIT Less CapEx to Interest Expense	-96.19	-113.65	-122.94	-166.22	-209.11	-258.54	-331.43	-527.41	-655.98	-	-1,643.83
NOPAT Less CapEx to Interest Expense	-72.52	-84.35	-92.61	-126.92	-155.23	-185.04	-244.59	-377.29	-490.44	-	-1,201.01
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%

Financials Breakdown Chart

Key Financial Trends

Here are key takeaways from Absci's latest quarterly results and balance sheets (covering the last four years up to Q4 2025). The company remains in a heavy burn mode, but has used equity financing to bolster liquidity.

Equity financing boosted liquidity in 2025: In Q3 2025 Absci issued common equity that generated about $60.1M in proceeds, with net financing cash inflows around $60.3M. This helped lift total equity to roughly $210M and extended its runway for R&D milestones.
Positive financing activity across multiple periods: Absci continued to post positive net cash from financing activities in 2025 (notably Q2 and Q3), providing liquidity support to fund ongoing operations and development costs.
Solid equity cushion relative to liabilities (late 2025): The Q4 2025 balance sheet shows total equity around $210.3M against liabilities of about $34.7M, indicating a sizable equity cushion that reduces near-term solvency risk even as cash burn persists.
Revenue remains very small: For Q4 2025, operating revenue was $0.65M versus operating expenses of $31.69M, underscoring Absci's continuing focus on development with minimal near-term revenue.
High R&D and SG&A burn typical of biotech: R&D expense in Q4 2025 was $25.35M and SG&A was $8.62M, highlighting a substantial burn relative to revenue as the company pursues pipeline development.
Ongoing dilution pressure observed: Weighted shares outstanding are large (roughly 136.8M basic and about 153.0M diluted in Q4 2025), suggesting that capital-raising to fund operations could continue to dilute existing shareholders.
Persistent net losses: Net income attributable to common shareholders in Q4 2025 was about -$29.56M (ongoing trend of large quarterly losses).
Continued operating cash burn: Net cash from continuing operating activities in Q4 2025 was around -$29.18M, indicating ongoing quarterly cash burn despite financing activity.
Large cumulative deficits: Retained earnings sit deeply negative (around -$595.22M at end of Q4 2025), reflecting a long-running cumulative deficit that necessitates continual external funding.

05/16/26 09:54 AM ETAI Generated. May Contain Errors.

Absci Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Absci's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Absci's net income appears to be on an upward trend, with a most recent value of -$115.18 million in 2025, rising from -$14.35 million in 2020. The previous period was -$103.11 million in 2024. See Absci's forecast for analyst expectations on what's next for the company.

Absci's total operating income in 2025 was -$120.32 million, based on the following breakdown:

Total Gross Profit: $2.80 million
Total Operating Expenses: $123.12 million

Over the last 5 years, Absci's total revenue changed from $4.78 million in 2020 to $2.80 million in 2025, a change of -41.4%.

Absci's total liabilities were at $26.85 million at the end of 2025, a 22.1% decrease from 2024, and a 24.5% increase since 2020.

In the past 5 years, Absci's cash and equivalents has ranged from $20.03 million in 2025 to $252.57 million in 2021, and is currently $20.03 million as of their latest financial filing in 2025.

Over the last 5 years, Absci's book value per share changed from -5.77 in 2020 to 1.26 in 2025, a change of -121.8%.

Related Companies

Financial statements for NASDAQ:ABSI last updated on 5/12/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Absci (ABSI) Financials

Financials Breakdown Chart

Key Financial Trends

Absci Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Absci (ABSI) Financials

Annual Income Statements for Absci

Quarterly Income Statements for Absci

Annual Cash Flow Statements for Absci

Quarterly Cash Flow Statements for Absci

Annual Balance Sheets for Absci

Quarterly Balance Sheets for Absci

Annual Metrics And Ratios for Absci

Quarterly Metrics And Ratios for Absci

Financials Breakdown Chart

Key Financial Trends

Absci Financials - Frequently Asked Questions

When does Absci's fiscal year end?

How has Absci's net income changed over the last 5 years?

What is Absci's operating income?

How has Absci's revenue changed over the last 5 years?

How much debt does Absci have?

How much cash does Absci have?

How has Absci's book value per share changed over the last 5 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools